SCHEMBL9290644

SCHEMBL9290644

CCN(CC)CCOc1cc(CNS(=O)(=O)c2ccc(Cl)s2)nc(-c2ccccn2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
TP53 P04637 3/20 0.42
THRB P10828 1/20 0.42
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
KDM4E B2RXH2 1/20 0.41
PKM P14618 1/20 0.41
ALDH1A1 P00352 3/20 0.40
TSHR P16473 2/20 0.40
MAPT P10636 2/20 0.40
POLB P06746 1/20 0.40
HTT P42858 1/20 0.40
GAA P10253 1/20 0.40
ESR1 P03372 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ESR2 Q92731 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9290572 0.91 KDM4E (0.43) L3MBTL1TP53KMT2AMEN1KDM4E
SCHEMBL9290651 0.87 NPY5R (0.44) HPGDL3MBTL1TP53KMT2AMEN1
SCHEMBL9290541 0.86 TP53 (0.52) HPGDALOX15L3MBTL1TP53THRB
SCHEMBL9290602 0.85 HTT (0.36) L3MBTL1TP53KMT2AMEN1KDM4E
SCHEMBL9290569 0.79 LYN (0.39) L3MBTL1TP53KMT2AMEN1KDM4E
SCHEMBL9290595 0.79 HPGD (0.48) HPGDALOX15L3MBTL1TP53THRB
SCHEMBL9290649 0.77 LYN (0.36) L3MBTL1TP53KMT2AMEN1KDM4E
SCHEMBL9290536 0.76 KDM4E (0.54) TP53THRBKDM4EPKMTSHR
SCHEMBL9290639 0.76 LYN (0.39) L3MBTL1TP53KMT2AMEN1KDM4E
SCHEMBL9290653 0.76 KDM4E (0.48) TP53THRBKDM4EPKMTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2643299-B1 BIPYRIDINE SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES OR CONDITIONS NOSCIRA SA (ES) 2016-06-22 EP disclosed
US-9284296-B2 Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions AUBERGINE PHARMACEUTICALS LLC (US) 2016-03-15 US disclosed
WO-2012069428-A1 BIPYRIDINE SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES OR CONDITIONS NOSCIRA, S.A. (ES) 2012-05-31 WO disclosed